Observed Signal · Nov 5, 2026 · earnings · Source: SEC API · Impact: 3.8/5
Doximity Reports Q2 Fiscal 2027 Revenue of $174.5 Million and Lower Net Income
Doximity, Inc. reported financial results for the second fiscal quarter ended September 30, 2026, generating revenue of $174.5 million, up 4% year-over-year from $168.5 million. Growth was primarily driven by subscription revenue expansions and new customer additions. However, net income fell 44% year-over-year to $34.7 million from $62.1 million, impacted by higher cloud hosting and software infrastructure costs to support AI initiatives, as well as an increase in stock-based compensation and operating expenses. Operating income for the quarter reached $43.9 million compared to $63.7 million in the prior-year period. Doximity repurchased 2.5 million shares of Class A common stock for $54.4 million during the quarter and settled its final contingent earn-out liability related to the AMiON acquisition. The company also reached a confidential settlement dismissing the OpenEvidence AI litigation.
The report reflects deceleration in top-line growth (4% YoY) alongside margin compression caused by accelerated investments into AI infrastructure and stock-based compensation, while cash flow generation and the balance sheet remain solid.
MARKET SIGNALS
Track Doximity Signals & Strategic Shifts
Polaris7 connects regulatory filings, primary sources, leadership changes, and M&A activity into structured intelligence. Set up your Polaris7 workspace to monitor relevant companies in your executive briefing.
- Verified primary sources
- Automated briefings
- Instant watchlist setup
Key Takeaways & Evidence Grounding
- Q2 fiscal 2027 revenue increased 4% year-over-year to $174.5 million, with subscription revenue accounting for $162.6 million (93% of total revenue).
- Net income dropped 44% year-over-year to $34.7 million, with operating margin declining as cost of revenue rose 54% due to AI and cloud infrastructure costs.
- Repurchased 2.51 million shares of Class A common stock in Q2 for $54.4 million, leaving $346.7 million authorized under the share repurchase program.
- Quarterly unique active providers using Workflow Tools increased approximately 34% year-over-year, supported by adoption of the Clinical AI Suite.
- Doximity announced its financial results for the second fiscal quarter ended September 30, 2026.
- The press release covering fiscal 2027 second-quarter performance was furnished as Exhibit 99.1.
- The filing was executed and signed by Chief Financial Officer Matthew Sonefeldt on November 5, 2026.
Connected Companies & Entities
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Doximity Faces Securities Fraud Class Action Lawsuit
Schall, Brown & Schwartz LLP (SBS) has announced a class action lawsuit against Doximity, Inc. (NYSE: DOCS) for alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The complaint claims Doximity made false and misleading statements, overstating the positive impact of its Newsfeed product on revenue growth and misleading investors about its advertising delivery methods, which included banner ads and newsletters. The class period is from August 8, 2024, to May 13, 2026, with a deadline of November 16, 2026, for investors to seek lead plaintiff appointment. Investors who purchased shares during this period may be eligible for recovery.
Software Stocks Recover 40% From SaaSpocalypse Low
The software sector has rebounded nearly 40% from its April lows, following the "SaaSpocalypse" selloff triggered by AI disruption fears. Analysts at Jefferies recommend focusing on data platforms and cybersecurity, which show more reliable AI monetization than consumer apps. They highlight Snowflake, Dynatrace, Palo Alto Networks, and Okta as key picks. Snowflake shares surged 22% after beating Q2 earnings, while Palo Alto also surpassed estimates. Doximity's stock doubled after its CEO cited a 10x return on AI search investment. Meanwhile, Salesforce and Anthropic CEOs stressed their complementary relationship rather than competition. The recovery underscores software's durable moats, including proprietary data and sticky workflows, even as frontier labs partner with established vendors.
Novant Health Partners with Doximity to Bring Evidence-Based Clinical AI Into Epic
Doximity announces new partnerships with Novant Health and Penn Highlands Healthcare to deploy its Clinical AI Suite, and releases the 2026 Physician Compensation Report highlighting AI fluency as a career advantage.
WATCHLIST & BRIEFINGS
Receive future signals for Doximity & competitors in your briefing
Stay ahead of material M&A deals, leadership changes, account wins, and product rollouts. Polaris7 connects primary filings, company newsrooms, and trade reporting directly into your executive briefing.
- Regular primary-source checks
- Structured Watchlist briefings
- Preserves current context
Market Signal Monitoring
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
Monitor Doximity
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
